Search

Your search keyword '"Bansal-Travers, Maansi"' showing total 640 results

Search Constraints

Start Over You searched for: Author "Bansal-Travers, Maansi" Remove constraint Author: "Bansal-Travers, Maansi"
640 results on '"Bansal-Travers, Maansi"'

Search Results

201. Evaluation of a dedicated institutional tobacco cessation service for thoracic clinic cancer patients.

202. Electronic Nicotine Delivery Systems

203. US Smokers' Beliefs, Experiences and Perceptions of Different Cigarette Variants Before and After the FSPTCA Ban on Misleading Descriptors Such as "Light," "Mild," or "Low".

204. Validation of a Measure of Normative Beliefs About Smokeless Tobacco Use.

205. Psychometric Characteristics of the Brief Wisconsin Inventory of Smoking Dependence Motives Among a Nonclinical Sample of Smokers.

206. Attention and Recall of Point-of-sale Tobacco Marketing: A Mobile Eye-Tracking Pilot Study.

210. Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013–2014

215. Filter presence and tipping paper color influence consumer perceptions of cigarettes.

216. The prevalence of brand switching among adult smokers in the USA, 2006-2011: findings from the ITC US surveys.

218. The Use of Cigarette Package Inserts to Supplement Pictorial Health Warnings: An Evaluation of the Canadian Policy.

219. Tobacco Cessation May Improve Lung Cancer Patient Survival.

220. Pictorial health warning label content and smokers’ understanding of smoking-related risks—a cross-country comparison.

221. Longer term impact of cigarette package warnings in Australia compared with the United Kingdom and Canada.

222. Factors associated with changes in flavored tobacco products used: Findings from wave 2 and wave 3 (2014-2016) of the population assessment of tobacco and health (PATH) study.

223. Trends in the use of premium and discount cigarette brands: findings from the ITC US Surveys (2002-2011).

224. Relationship of Cigarette-Related Perceptions to Cigarette Design Features: Findings From the 2009 ITC U.S. Survey.

225. Promoting cessation resources through cigarette package warning labels: a longitudinal survey with adult smokers in Canada, Australia and Mexico.

226. Food and Drug Administration Evaluation and Cigarette Smoking Risk Perceptions.

227. Educating smokers about their cigarettes and nicotine medications.

230. Respiratory symptoms and outcomes among cigar smokers: findings from the Population Assessment of Tobacco and Health (PATH) study waves 2–5 (2014–2019).

231. Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors.

232. Correlates of Transitions in Tobacco Product Use by U.S. Adult Tobacco Users between 2013–2014 and 2014–2015: Findings from the PATH Study Wave 1 and Wave 2.

233. Transitions in Tobacco Product Use by U.S. Adults between 2013–2014 and 2014–2015: Findings from the PATH Study Wave 1 and Wave 2.

234. Switching Between Menthol and Nonmenthol Cigarettes: Findings From the International Tobacco Control Four Country Survey, U.S. Cohort.

235. Perceptions of harmfulness of heated tobacco and nicotine vaping products compared to cigarettes, and the association of advertising exposure on harm perceptions among adults who smoke in South Korea: Cross-sectional findings from the 2020 ITC Korea Survey.

236. Patterns of Premium and Nonpremium Cigar Use in the United States: Findings from Wave 6 (2021) of the Population Assessment of Tobacco and Health Study.

237. Support for pictorial health warning labels on cigarette packages in the United States among adults who currently smoke or quit smoking: Findings from the ITC US Smoking and Vaping Surveys.

238. Predictors of smoking cessation among adult smokers in Malaysia and Thailand: Findings from the International Tobacco Control Southeast Asia Survey.

239. Oral Nicotine Product Awareness and Use Among People Who Smoke and Vape in the U.S.

240. E-Cigarette Flavors, Devices, and Brands Used by Youths Before and After Partial Flavor Restrictions in the United States: Canada, England, and the United States, 2017‒2020.

241. Menthol and Mint Cigarettes and Cigars: Initiation and Progression in Youth, Young Adults and Adults in Waves 1-4 of the PATH Study, 2013-2017.

243. Harm perceptions and tobacco use initiation among youth in Wave 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study.

244. Youth perception of harm and addictiveness of tobacco products: Findings from the Population Assessment of Tobacco and Health Study (Wave 1).

245. Associations of risk factors of e-cigarette and cigarette use and susceptibility to use among baseline PATH study youth participants (2013-2014).

246. U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013-14 baseline wave 1 of the path study.

247. US Adult Cigar Smoking Patterns, Purchasing Behaviors, and Reasons for Use According to Cigar Type: Findings From the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.

248. Path analysis of warning label effects on negative emotions and quit attempts: A longitudinal study of smokers in Australia, Canada, Mexico, and the US.

249. Susceptibility to tobacco product use among youth in wave 1 of the population Assessment of tobacco and health (PATH) study.

250. Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014.

Catalog

Books, media, physical & digital resources